Catalent Inc (NASDAQ:CTLT) – William Blair cut their Q1 2018 earnings per share estimates for Catalent in a report issued on Wednesday. William Blair analyst J. Kreger now forecasts that the company will post earnings of $0.15 per share for the quarter, down from their prior forecast of $0.19. William Blair currently has a “Ourperform” rating on the stock. William Blair also issued estimates for Catalent’s Q3 2018 earnings at $0.39 EPS, Q4 2018 earnings at $0.61 EPS, FY2018 earnings at $1.52 EPS and FY2019 earnings at $1.71 EPS.

Several other research firms have also recently weighed in on CTLT. Zacks Investment Research upgraded shares of Catalent from a “hold” rating to a “buy” rating and set a $39.00 price target on the stock in a report on Tuesday, August 22nd. BidaskClub upgraded shares of Catalent from a “hold” rating to a “buy” rating in a report on Friday, September 8th. Bank of America Corporation restated a “buy” rating and set a $38.00 price target (up from $37.00) on shares of Catalent in a report on Friday, July 21st. ValuEngine upgraded shares of Catalent from a “hold” rating to a “buy” rating in a report on Thursday, September 7th. Finally, J P Morgan Chase & Co restated a “buy” rating and set a $40.00 price target on shares of Catalent in a report on Tuesday, August 29th. Five research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $38.64.

COPYRIGHT VIOLATION NOTICE: This news story was published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.dailypolitical.com/2017/09/21/catalent-inc-ctlt-to-post-q1-2018-earnings-of-0-15-per-share-william-blair-forecasts.html.

Shares of Catalent (CTLT) traded up 2.76% during midday trading on Thursday, hitting $40.27. 348,651 shares of the stock were exchanged. The stock has a market capitalization of $5.04 billion and a price-to-earnings ratio of 46.29. Catalent has a 1-year low of $21.83 and a 1-year high of $42.22. The firm’s 50 day moving average is $37.19 and its 200-day moving average is $33.73.

Catalent (NASDAQ:CTLT) last issued its earnings results on Monday, August 28th. The company reported $0.65 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.57 by $0.08. The company had revenue of $616.90 million for the quarter, compared to analysts’ expectations of $547.48 million. Catalent had a net margin of 10.02% and a return on equity of 36.29%. Catalent’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.52 EPS.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. boosted its stake in Catalent by 15.2% in the second quarter. BlackRock Inc. now owns 17,512,661 shares of the company’s stock valued at $614,695,000 after acquiring an additional 2,316,849 shares during the last quarter. Vanguard Group Inc. boosted its stake in Catalent by 3.8% in the second quarter. Vanguard Group Inc. now owns 10,119,431 shares of the company’s stock valued at $355,192,000 after acquiring an additional 369,526 shares during the last quarter. Janus Henderson Group PLC purchased a new position in Catalent in the second quarter valued at about $239,629,000. JPMorgan Chase & Co. boosted its stake in Catalent by 4.6% in the second quarter. JPMorgan Chase & Co. now owns 5,139,690 shares of the company’s stock valued at $180,403,000 after acquiring an additional 226,705 shares during the last quarter. Finally, State Street Corp boosted its stake in Catalent by 10.7% in the second quarter. State Street Corp now owns 4,315,841 shares of the company’s stock valued at $151,488,000 after acquiring an additional 418,196 shares during the last quarter.

In other Catalent news, SVP Christine Dolan sold 1,594 shares of the business’s stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $38.75, for a total value of $61,767.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Catalent Company Profile

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Earnings History and Estimates for Catalent (NASDAQ:CTLT)

Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with MarketBeat.com's FREE daily email newsletter.